Home > Insider Trading > Filing (0001209191-14-060582)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1453943	Thomas Connolly	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210	Svp, Human Resources	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-09-30	2,813	$53.74	18,597	No	4	M	Direct
Common Stock	Acquisiton	2014-09-30	1,875	$45.11	20,472	No	4	M	Direct
Common Stock	Acquisiton	2014-09-30	1,500	$83.36	21,972	No	4	M	Direct
Common Stock	Acquisiton	2014-09-30	7,844	$77.31	29,816	No	4	M	Direct
Common Stock	Disposition	2014-09-30	1,800	$111.29	28,016	No	4	S	Direct
Common Stock	Disposition	2014-09-30	5,300	$112.18	22,716	No	4	S	Direct
Common Stock	Disposition	2014-09-30	4,071	$113.03	18,645	No	4	S	Direct
Common Stock	Disposition	2014-09-30	3,000	$113.89	15,645	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2014-09-30	2,813	$0.00	2,813	$53.74
Common Stock	Stock Option (right to buy)	Disposition	2014-09-30	1,875	$0.00	1,875	$45.11
Common Stock	Stock Option (right to buy)	Disposition	2014-09-30	1,500	$0.00	1,500	$83.36
Common Stock	Stock Option (right to buy)	Disposition	2014-09-30	7,844	$0.00	7,844	$77.31

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
7,500	2022-09-03	No	4	M	Direct
9,375	2023-02-04	No	4	M	Direct
4,500	2023-07-29	No	4	M	Direct
54,906	2024-02-04	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	150	Indirect	401(k)

Footnotes

Transaction made pursuant to Mr. Connolly's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $111.29 (range $110.61 to $111.58).
Mr. Connolly undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $112.18 (range $111.61 to $112.60).
Open market sales reported on this line occurred at a weighted average price of $113.03 (range $112.61 to $113.59).
Open market sales reported on this line occurred at a weighted average price of $113.89 (range $113.61 to $114.31).
The option vests in 16 quarterly installments from 09/04/2012.
The option vests in 16 quarterly installments from 02/05/2013.
The option vests in 16 quarterly installments from 07/30/2013.
The option vests in 16 quarterly installments from 02/05/2014.